Debiopharm and Ipsen Extend Their Strategic Decapeptyl (triptorelin) Partnership for Another 15 Years Read more
Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development Read more
Eton Pharma Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update Read more
BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan Read more
FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma Read more